CNSI Cambridge Neuroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: TheSlowLane who wrote (181)	6/24/1997 10:01:00 PM
From: cur	of 675

Can anyone tell me just what the risks/side effects of Cerestat use are? I thought that Cerestat was a competitive inhibitor of the NMDA receptor and wouldn't have the psychotic/hallucinogenic effects of noncompetitive inhibitors (such as MK801). Also, as a naive thought, was CNSI's action an independent move? That is, did they do it (suspend trial for further evaluation) without a request from the FDA to do so. If that's the case, can we hope/interpret this as an overly conservative move? Call me a fool, but I'm increasing my position in CNSI. Wish CNSI luck.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next